Medical Journals

Tetrahydrobiopterin Prevents Endothelial Dysfunction and Restores Adiponectin Levels in Rats.

Authors:
  • Wang Xi
  • Hattori Yoshiyuki
  • Satoh Hiroko
  • Iwata Chigusa
  • Banba Nobuyuki
  • Monden Tsuyoshi
  • Uchida Kohsuke
  • Kamikawa Yuichiro
  • Kasai Kikuo

From: Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi, Japan.

European journal of pharmacology

  • Publish Date: Jan 2007
  • ISSN: 0014-2999
  • Volume: 555
  • Issue: 1
  • Pages: 48-53
  • Medium: Print
  • Language: English
  • Citation (JAMA): Wang Xi, Hattori Yoshiyuki, Satoh Hiroko, et al. Tetrahydrobiopterin Prevents Endothelial Dysfunction and Restores Adiponectin Levels in Rats.. Eur. J. Pharmacol. Jan 2007;555:48-53

Abstract

Oxidative stress induces endothelial dysfunction and hypoadiponectinemia. We previously reported that supplementation with tetrahydrobiopterin (BH4), one of the most potent naturally occurring reducing agents and an essential cofactor of enzymatic NO synthase (NOS), ameliorates endothelial dysfunction and reverses hypoadiponectinemia as a result of oxidative stress in rats. To further confirm this hypothesis, we investigated the effects of treatment with BH4 on endothelium-dependent relaxation and adiponectin levels during oxidative stress in fructose-fed rats, which provide an animal model for the metabolic syndrome. Ingestion of a fructose diet for 8 weeks significantly impaired endothelium-dependent arterial relaxation in aortic strips and decreased plasma adiponectin levels, as well as adiponectin mRNA levels within adipose tissue. However, oral supplementation with BH4 (10 mg/kg day) over the final 4 weeks leads to a significant partial reversal of impaired endothelium-dependent arterial relaxation, as well as normalization of plasma adiponectin and fat adiponectin mRNA levels. Moreover, BH4 treatment of the fructose-fed rats significantly reduced the lipid peroxidation content of aorta, heart, liver, and kidney tissues, which were increased in fructose-fed rats. This effect of BH4 treatment may be due to its function as a cofactor for eNOS, as well as its anti-oxidative effects. Thus, BH4 might show promise for the treatment of oxidative stress-induced disorders, including the metabolic syndrome.

Mesh Headings (Keywords): Adiponectin, Adipose Tissue, Animals, Aorta, Thoracic, Biopterin, Blood Pressure, Endothelium, Vascular, Fructose, Male, Metabolic Syndrome X, Myocardium, Nitrates, Nitric Oxide Synthase Type II, Nitric Oxide Synthase Type III, Nitrites, Oxidative Stress, RNA, Messenger, Rats, Rats, Sprague-Dawley, Triglycerides, Vasodilation


Check for Full Text / PubMed Unique Identifier (PMID): 17098227


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.